Anxo Pharmaceutical Co., Ltd.(TW:6677)
NT$20.95+0.15 (+0.72%)
TW:6677
Anxo Pharmaceutical Co., Ltd. financials statements
NT$20.95
At close:+0.15 (+0.72%)
Anxo Pharmaceutical Co., Ltd. (6677) Income Statement
Anxo Pharmaceutical Co., Ltd. Income Statement
Last quarter (Q2 2026), Anxo Pharmaceutical Co., Ltd.'s total revenue was NT$438.39M, an increase of 5.67% from the same quarter last year. In Q2, Anxo Pharmaceutical Co., Ltd.'s net income was NT$-6.59M. See Anxo Pharmaceutical Co., Ltd.’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| NT$ 843.26M | NT$ 895.32M | NT$ 939.94M | NT$ 866.27M | NT$ 824.10M | |
| NT$ 300.18M | NT$ 325.48M | NT$ 396.93M | NT$ 331.46M | NT$ 331.66M | |
| NT$ 343.87M | NT$ 381.91M | NT$ 343.62M | NT$ 325.25M | NT$ 291.81M | |
| Depreciation and Amortization | NT$ 76.21M | NT$ 76.71M | NT$ 74.56M | NT$ 74.22M | NT$ 74.38M |
| NT$ 32.51M | NT$ 33.37M | NT$ 131.31M | NT$ 84.96M | NT$ 111.22M | |
| NT$ -43.69M | NT$ -56.42M | NT$ 53.15M | NT$ 5.95M | NT$ 40.10M | |
| NT$ -1.90M | NT$ -3.60M | NT$ -14.63M | NT$ -10.66M | NT$ -15.77M | |
| NT$ -45.60M | NT$ -60.02M | NT$ 38.68M | NT$ -4.71M | NT$ 24.33M | |
| NT$ -34.13M | NT$ -57.21M | NT$ 21.86M | NT$ -12.56M | NT$ 19.23M | |
| Per Share Metrics | |||||
| Basic EPS | NT$ -0.61 | NT$ -1.03 | NT$ 0.43 | NT$ -0.26 | NT$ 0.39 |
| Diluted EPS | NT$ -0.61 | NT$ -1.03 | NT$ 0.42 | NT$ -0.26 | NT$ 0.38 |
| Weighted Average Shares Outstanding | 55.96M | 55.72M | 50.84M | 48.16M | 49.94M |
| Weighted Average Shares Outstanding (Diluted) | 55.96M | 55.72M | 51.59M | 48.16M | 50.27M |
Currency in TWD
